be_ixf;ym_202009 d_27; ct_100

Select Page

Wall Street Veteran Pinpoints No. 1 Biotech Stock

A game-changing medical device is about to make some well-positioned investors very happy.

The company behind this device has more than 100 patents, saw its earnings surge 768% year over year last quarter, has a track record of growth and just signed two major deals…

One with Teva Pharmaceutical, the world’s largest generic drugmaker, with a $12.5 billion market cap.

The other with Pfizer, the world’s largest pharmaceutical corporation with a $228.5 billion market cap.

This New Jersey-based company is perfectly primed for a takeover – very soon.

That’s why Wall Street veteran Jeff Yastine is certain that there is a very unique opportunity for savvy investors.

And at less than $5 per share, the rewards for those who get in NOW could be tremendous.

Yastine just created a special presentation detailing what he believes is the No. 1 biotech stock to invest in today.

See it now.

About Banyan Hill

Banyan Hill Publishing logo At Banyan Hill Publishing, we are a network of global experts in asset protection, investing and entrepreneurship who have united together to help hardworking Americans obtain the freedom of “total wealth” — the ability to make your own financial decisions, grow your wealth and be free from the financial concerns that plague so many of us.

Meeting Our Gurus

Paul Mampilly Charles Mizrahi Michael Carr, CMT, CFTe Ted Bauman Brian Christopher Chad Shoop, CMT Matt Badiali Ian King